0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global DNA Vaccination Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-34F5734
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global and United States DNA Vaccination Market Report Forecast 2022 2028
BUY CHAPTERS

Global DNA Vaccination Market Research Report 2025

Code: QYRE-Auto-34F5734
Report
September 2025
Pages:60
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

DNA Vaccination Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

DNA Vaccination Market

DNA Vaccination Market

The global market for DNA Vaccination was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
DNA vaccination is a technique for protecting against disease by injection with genetically engineered DNA so cells directly produce an antigen, producing a protective immunological response.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for DNA Vaccination, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DNA Vaccination.
The DNA Vaccination market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global DNA Vaccination market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DNA Vaccination companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of DNA Vaccination Market Report

Report Metric Details
Report Name DNA Vaccination Market
CAGR 5%
Segment by Type
  • Human DNA Vaccines
  • Animal DNA Vaccines
Segment by Application
  • Hospitals
  • Research and Academic Laboratories
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Inovio Pharmaceuticals, Merck, Astellas Pharma, Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of DNA Vaccination company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the DNA Vaccination Market report?

Ans: The main players in the DNA Vaccination Market are Inovio Pharmaceuticals, Merck, Astellas Pharma, Pfizer

What are the Application segmentation covered in the DNA Vaccination Market report?

Ans: The Applications covered in the DNA Vaccination Market report are Hospitals, Research and Academic Laboratories, Others

What are the Type segmentation covered in the DNA Vaccination Market report?

Ans: The Types covered in the DNA Vaccination Market report are Human DNA Vaccines, Animal DNA Vaccines

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global DNA Vaccination Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Human DNA Vaccines
1.2.3 Animal DNA Vaccines
1.3 Market by Application
1.3.1 Global DNA Vaccination Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Research and Academic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global DNA Vaccination Market Perspective (2020-2031)
2.2 Global DNA Vaccination Growth Trends by Region
2.2.1 Global DNA Vaccination Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 DNA Vaccination Historic Market Size by Region (2020-2025)
2.2.3 DNA Vaccination Forecasted Market Size by Region (2026-2031)
2.3 DNA Vaccination Market Dynamics
2.3.1 DNA Vaccination Industry Trends
2.3.2 DNA Vaccination Market Drivers
2.3.3 DNA Vaccination Market Challenges
2.3.4 DNA Vaccination Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top DNA Vaccination Players by Revenue
3.1.1 Global Top DNA Vaccination Players by Revenue (2020-2025)
3.1.2 Global DNA Vaccination Revenue Market Share by Players (2020-2025)
3.2 Global DNA Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by DNA Vaccination Revenue
3.4 Global DNA Vaccination Market Concentration Ratio
3.4.1 Global DNA Vaccination Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by DNA Vaccination Revenue in 2024
3.5 Global Key Players of DNA Vaccination Head office and Area Served
3.6 Global Key Players of DNA Vaccination, Product and Application
3.7 Global Key Players of DNA Vaccination, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 DNA Vaccination Breakdown Data by Type
4.1 Global DNA Vaccination Historic Market Size by Type (2020-2025)
4.2 Global DNA Vaccination Forecasted Market Size by Type (2026-2031)
5 DNA Vaccination Breakdown Data by Application
5.1 Global DNA Vaccination Historic Market Size by Application (2020-2025)
5.2 Global DNA Vaccination Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America DNA Vaccination Market Size (2020-2031)
6.2 North America DNA Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America DNA Vaccination Market Size by Country (2020-2025)
6.4 North America DNA Vaccination Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe DNA Vaccination Market Size (2020-2031)
7.2 Europe DNA Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe DNA Vaccination Market Size by Country (2020-2025)
7.4 Europe DNA Vaccination Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific DNA Vaccination Market Size (2020-2031)
8.2 Asia-Pacific DNA Vaccination Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific DNA Vaccination Market Size by Region (2020-2025)
8.4 Asia-Pacific DNA Vaccination Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America DNA Vaccination Market Size (2020-2031)
9.2 Latin America DNA Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America DNA Vaccination Market Size by Country (2020-2025)
9.4 Latin America DNA Vaccination Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa DNA Vaccination Market Size (2020-2031)
10.2 Middle East & Africa DNA Vaccination Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa DNA Vaccination Market Size by Country (2020-2025)
10.4 Middle East & Africa DNA Vaccination Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Inovio Pharmaceuticals
11.1.1 Inovio Pharmaceuticals Company Details
11.1.2 Inovio Pharmaceuticals Business Overview
11.1.3 Inovio Pharmaceuticals DNA Vaccination Introduction
11.1.4 Inovio Pharmaceuticals Revenue in DNA Vaccination Business (2020-2025)
11.1.5 Inovio Pharmaceuticals Recent Development
11.2 Merck
11.2.1 Merck Company Details
11.2.2 Merck Business Overview
11.2.3 Merck DNA Vaccination Introduction
11.2.4 Merck Revenue in DNA Vaccination Business (2020-2025)
11.2.5 Merck Recent Development
11.3 Astellas Pharma
11.3.1 Astellas Pharma Company Details
11.3.2 Astellas Pharma Business Overview
11.3.3 Astellas Pharma DNA Vaccination Introduction
11.3.4 Astellas Pharma Revenue in DNA Vaccination Business (2020-2025)
11.3.5 Astellas Pharma Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer DNA Vaccination Introduction
11.4.4 Pfizer Revenue in DNA Vaccination Business (2020-2025)
11.4.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global DNA Vaccination Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Human DNA Vaccines
 Table 3. Key Players of Animal DNA Vaccines
 Table 4. Global DNA Vaccination Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global DNA Vaccination Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global DNA Vaccination Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global DNA Vaccination Market Share by Region (2020-2025)
 Table 8. Global DNA Vaccination Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global DNA Vaccination Market Share by Region (2026-2031)
 Table 10. DNA Vaccination Market Trends
 Table 11. DNA Vaccination Market Drivers
 Table 12. DNA Vaccination Market Challenges
 Table 13. DNA Vaccination Market Restraints
 Table 14. Global DNA Vaccination Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global DNA Vaccination Market Share by Players (2020-2025)
 Table 16. Global Top DNA Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Vaccination as of 2024)
 Table 17. Ranking of Global Top DNA Vaccination Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by DNA Vaccination Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of DNA Vaccination, Headquarters and Area Served
 Table 20. Global Key Players of DNA Vaccination, Product and Application
 Table 21. Global Key Players of DNA Vaccination, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global DNA Vaccination Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global DNA Vaccination Revenue Market Share by Type (2020-2025)
 Table 25. Global DNA Vaccination Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global DNA Vaccination Revenue Market Share by Type (2026-2031)
 Table 27. Global DNA Vaccination Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global DNA Vaccination Revenue Market Share by Application (2020-2025)
 Table 29. Global DNA Vaccination Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global DNA Vaccination Revenue Market Share by Application (2026-2031)
 Table 31. North America DNA Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America DNA Vaccination Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America DNA Vaccination Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe DNA Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe DNA Vaccination Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe DNA Vaccination Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific DNA Vaccination Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific DNA Vaccination Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific DNA Vaccination Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America DNA Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America DNA Vaccination Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America DNA Vaccination Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa DNA Vaccination Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa DNA Vaccination Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa DNA Vaccination Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Inovio Pharmaceuticals Company Details
 Table 47. Inovio Pharmaceuticals Business Overview
 Table 48. Inovio Pharmaceuticals DNA Vaccination Product
 Table 49. Inovio Pharmaceuticals Revenue in DNA Vaccination Business (2020-2025) & (US$ Million)
 Table 50. Inovio Pharmaceuticals Recent Development
 Table 51. Merck Company Details
 Table 52. Merck Business Overview
 Table 53. Merck DNA Vaccination Product
 Table 54. Merck Revenue in DNA Vaccination Business (2020-2025) & (US$ Million)
 Table 55. Merck Recent Development
 Table 56. Astellas Pharma Company Details
 Table 57. Astellas Pharma Business Overview
 Table 58. Astellas Pharma DNA Vaccination Product
 Table 59. Astellas Pharma Revenue in DNA Vaccination Business (2020-2025) & (US$ Million)
 Table 60. Astellas Pharma Recent Development
 Table 61. Pfizer Company Details
 Table 62. Pfizer Business Overview
 Table 63. Pfizer DNA Vaccination Product
 Table 64. Pfizer Revenue in DNA Vaccination Business (2020-2025) & (US$ Million)
 Table 65. Pfizer Recent Development
 Table 66. Research Programs/Design for This Report
 Table 67. Key Data Information from Secondary Sources
 Table 68. Key Data Information from Primary Sources
 Table 69. Authors List of This Report


List of Figures
 Figure 1. DNA Vaccination Picture
 Figure 2. Global DNA Vaccination Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global DNA Vaccination Market Share by Type: 2024 VS 2031
 Figure 4. Human DNA Vaccines Features
 Figure 5. Animal DNA Vaccines Features
 Figure 6. Global DNA Vaccination Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global DNA Vaccination Market Share by Application: 2024 VS 2031
 Figure 8. Hospitals Case Studies
 Figure 9. Research and Academic Laboratories Case Studies
 Figure 10. Others Case Studies
 Figure 11. DNA Vaccination Report Years Considered
 Figure 12. Global DNA Vaccination Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 13. Global DNA Vaccination Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global DNA Vaccination Market Share by Region: 2024 VS 2031
 Figure 15. Global DNA Vaccination Market Share by Players in 2024
 Figure 16. Global Top DNA Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA Vaccination as of 2024)
 Figure 17. The Top 10 and 5 Players Market Share by DNA Vaccination Revenue in 2024
 Figure 18. North America DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 19. North America DNA Vaccination Market Share by Country (2020-2031)
 Figure 20. United States DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Canada DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe DNA Vaccination Market Share by Country (2020-2031)
 Figure 24. Germany DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. France DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. U.K. DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Italy DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Russia DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Nordic Countries DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific DNA Vaccination Market Share by Region (2020-2031)
 Figure 32. China DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Japan DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. South Korea DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Southeast Asia DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. India DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Australia DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America DNA Vaccination Market Share by Country (2020-2031)
 Figure 40. Mexico DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Brazil DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa DNA Vaccination Market Share by Country (2020-2031)
 Figure 44. Turkey DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Saudi Arabia DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. UAE DNA Vaccination Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Inovio Pharmaceuticals Revenue Growth Rate in DNA Vaccination Business (2020-2025)
 Figure 48. Merck Revenue Growth Rate in DNA Vaccination Business (2020-2025)
 Figure 49. Astellas Pharma Revenue Growth Rate in DNA Vaccination Business (2020-2025)
 Figure 50. Pfizer Revenue Growth Rate in DNA Vaccination Business (2020-2025)
 Figure 51. Bottom-up and Top-down Approaches for This Report
 Figure 52. Data Triangulation
 Figure 53. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network